Literature DB >> 16601882

Biochemical compared to molecular diagnosis in acute intermittent porphyria.

U Grob1, H Puy, K Jacob, J C Deybach, J Kremer, M O Doss.   

Abstract

The biochemical and the molecular diagnoses of an inherited porphyria require experience. False positive or negative screening tests and the low penetrance of the disease make a correct diagnosis difficult.The biochemical and the molecular procedures for the diagnosis of acute intermittent porphyria were applied to five unrelated patients suffering from acute intermittent porphyria. All patients were shown to be gene carriers of acute intermittent porphyria by both methods. The two different possibilities of the diagnosis corresponded well. In a family definitively identified by molecular diagnosis of one of the patients and his relatives, the patient's two children were asymptomatic. His son was shown to be a gene carrier of the father's deficiency by biochemical as well as molecular analysis, whereas his daughter was not affected by acute intermittent porphyria.

Entities:  

Mesh:

Year:  2006        PMID: 16601882     DOI: 10.1007/s10545-006-0155-9

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  17 in total

1.  [Difficulties in diagnosis of intermittent porphyria].

Authors:  E N Skriabina; T S Bogdanova
Journal:  Klin Med (Mosk)       Date:  2002

2.  New mutations of the hydroxymethylbilane synthase gene in German patients with acute intermittent porphyria.

Authors:  U Gross; H Puy; M Doss; A M Robreau; Y Nordmann; M O Doss; J C Deybach
Journal:  Mol Cell Probes       Date:  1999-12       Impact factor: 2.365

Review 3.  Molecular diagnostics of acute intermittent porphyria.

Authors:  Raili Kauppinen
Journal:  Expert Rev Mol Diagn       Date:  2004-03       Impact factor: 5.225

4.  Acute intermittent porphyria: prevalence of mutations in the porphobilinogen deaminase gene in blood donors in France.

Authors:  Y Nordmann; H Puy; V Da Silva; S Simonin; A M Robreau; C Bonaiti; L N Phung; J C Deybach
Journal:  J Intern Med       Date:  1997-09       Impact factor: 8.989

5.  Molecular epidemiology and diagnosis of PBG deaminase gene defects in acute intermittent porphyria.

Authors:  H Puy; J C Deybach; J Lamoril; A M Robreau; V Da Silva; L Gouya; B Grandchamp; Y Nordmann
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

6.  Separation of lymphocytes, granulocytes, and monocytes from human blood using iodinated density gradient media.

Authors:  A Bøyum
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

7.  Diagnostic dilemmas in acute intermittent porphyria. A case report.

Authors:  Vembu Periasamy; Asmahan al Shubaili; Y Girsh
Journal:  Med Princ Pract       Date:  2002 Apr-Jun       Impact factor: 1.927

8.  Acute intermittent porphyria in childhood: a population-based study.

Authors:  J Hultdin; A Schmauch; A Wikberg; G Dahlquist; C Andersson
Journal:  Acta Paediatr       Date:  2003-05       Impact factor: 2.299

Review 9.  Homozygous acute intermittent porphyria in a 7-year-old boy with massive excretions of porphyrins and porphyrin precursors.

Authors:  J Hessels; G Voortman; A van der Wagen; C van der Elzen; H Scheffer; F M J Zuijderhoudt
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

10.  Molecular analysis of acute intermittent porphyria: mutation screening in 20 patients in Germany reveals 11 novel mutations.

Authors:  Léon von Brasch; Chuanbing Zang; Thomas Haverkamp; Horst Schlechte; Herbert Heckers; Petro E Petrides
Journal:  Blood Cells Mol Dis       Date:  2004 Mar-Apr       Impact factor: 3.039

View more
  1 in total

1.  The acute porphyrias: a diagnostic and therapeutic challenge in internal and emergency medicine.

Authors:  Paolo Ventura; Maria Domenica Cappellini; Emilio Rocchi
Journal:  Intern Emerg Med       Date:  2009-05-29       Impact factor: 3.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.